Niva Bupa Health Insurance Company
- Market cap
- ₹ 13,354 Cr.
- P/E
- 77.2x
- P/B
- 3.51x
- 52-week range
- 67.5 – 91.4
- ROE
- 3%
- ROCE
- 3%
- Dividend yield
- 0%
- Debt / equity
- 0.07
- Sector
- Insurance
- Industry
- General Insurance
- Listed on
- NSE, BSE
About
Niva Bupa Health Insurance Company Limited is an India-based standalone health insurer (SAHI), focused on the retail health market. The Company's products are categorized into retail products, which are intended for individuals and families, and group products, which are intended for employers and employees, as well as third parties such as customers of banks and other corporate agents. Its businesses include health insurance, personal accident and travel insurance. Its health insurance business includes both indemnity-based and benefit-based health insurance products which are offered to retail and group customers. Its personal accident business includes primarily benefit-based products offered to retail and group customers. Its travel insurance business includes a combination of indemnity-based and benefit-based products, along with travel inconvenience benefits. Its travel insurance products are offered to retail and group customers, including domestic and international travelers.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
General Insurance: 6 companies →Niva Bupa Health Insurance Company against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)77.2 against a typical 33.1: pricier than most peers (1st = cheapest).6th of 6
- Sales growth+27.9% against a typical +10.8% from a year earlier.1st of 6
- Profit growth+94.4% against a typical −7.9% from a year earlier.1st of 6
- Share price, 3 months−15% against a typical −6.7%.6th of 6
- Size₹ 13,354 Cr. market value against a typical ₹ 25,004.8 Cr. (1st = largest).3rd of 3
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated AAA to AA by 3 agencies- ICRA lowered its rating on 21 Aug 2026.
- The agencies don't fully agree: India Ratings says AAA, CARE says AA.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| India Ratings | IND AAA | Stable | 15 Oct 2026 |
| ICRA | [ICRA]AA+ | Stable | 21 Aug 2026 |
| CARE | CARE AA | Stable | 26 Jun 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 15 Oct 2026 | New rating | IND AAA | Low | India Ratings | ₹ 500 Cr. | |
| 21 Aug 2026 | ▼ Downgrade1 notch | [ICRA]AAA → [ICRA]AA+ | — | ICRA | ₹ 500 Cr. | |
| 16 Jul 2026 | New rating | [ICRA]AAA | — | ICRA | — | |
| 26 Jun 2026 | Reaffirmed | CARE AA | — | CARE | ₹ 250 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 4 Nov 2026Upcoming | Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026 |
| 30 Jul 2026 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising |
| 8 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 29 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 3 Nov 2025 | Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2025 |
| 31 Jul 2025 | Financial Results | To consider and approve the Unaudited financial results for the period ended June 30, 2025. |
| 7 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 969 | 1,026 | 1,316 | 1,124 | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 | 1,611 | 2,251 | 2,471 |
| Expenses | 1,027 | 1,071 | 1,215 | 1,228 | 1,387 | 1,282 | 1,420 | 1,834 | 1,627 | 1,705 | 2,069 | 2,287 |
| Operating Profit | −58 | −46 | 100 | −103 | −66 | −24 | 251 | 98 | −53 | −94 | 182 | 184 |
| OPM % | −6% | −4.4% | 8% | −9% | −5% | −1.9% | 15% | 5% | −3.4% | −6% | 8% | 7% |
| Other Income | 50 | 50 | 57 | 84 | 79 | 37 | −45 | 0 | 18 | 7 | −1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −8 | 5 | 157 | −19 | 13 | 13 | 206 | 98 | −35 | −88 | 181 | 184 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 27% | 0% | 0% | 12% | 25% |
| Net Profit | −8 | 5 | 157 | −19 | 13 | 13 | 206 | 71 | −35 | −88 | 159 | 138 |
| EPS in Rs | — | — | — | — | — | 0.07 | 1.13 | 0.39 | −0.19 | −0.47 | 0.86 | 0.75 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 36%
- 3 Years
- 33%
- TTM
- 28%
- 10 Years
- —
- 5 Years
- 36%
- 3 Years
- 127%
- TTM
- −43%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 3%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Niva Bupa Health Insurance Company | ₹ 72.86 | ₹ 13,354 Cr. | 77.2x | 3.5x | 3% | — |
| Max Financial Services | ₹ 1,213.70 | ₹ 41,446 Cr. | 658.5x | 10x | 1.6% | 0.2% |
| Max India | ₹ 150.30 | ₹ 844 Cr. | — | 2.1x | −31.5% | −63.9% |
Management
- Krishnan Ramachandran
- Chief Executive Officer, Managing Director, Executive Director
- Ankur Kharbanda
- Deputy Chief Executive Officer, Executive Director
- Vishwanath Mahendra
- Chief Financial Officer, Executive Director
- Aparna Sharma
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.